Compromised Volumetric Bone Density and Microarchitecture in men with Congenital Hypogonadotropic Hypogonadism.

Details

Ressource 1Request a copy Sous embargo jusqu'au 10/03/2022.
State: Public
Version: Author's accepted manuscript
License: Not specified
Serval ID
serval:BIB_E824C9E353A9
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Compromised Volumetric Bone Density and Microarchitecture in men with Congenital Hypogonadotropic Hypogonadism.
Journal
The Journal of clinical endocrinology and metabolism
Author(s)
Ostertag A., Papadakis G.E., Collet C., Trabado S., Maione L., Pitteloud N., Bouligand J., De Vernejoul M.C., Cohen-Solal M., Young J.
ISSN
1945-7197 (Electronic)
ISSN-L
0021-972X
Publication state
In Press
Peer-reviewed
Oui
Language
english
Notes
Publication types: Journal Article
Publication Status: aheadofprint
Abstract
Men with Congenital Hypogonadotropic Hypogonadism (CHH) and Kallmann syndrome (KS) have both low circulating testosterone and estradiol levels. Whether bone structure is affected remains unknown.
To characterize bone geometry, volumetric density and microarchitecture in CHH/KS.
Cross-sectional study.
One tertiary academic French center.
51 genotyped CHH/KS patients and 40 healthy volunteers were included. Ninety-eight percent of CHH/KS men had received testosterone and/or combined gonadotropins.
High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT), Dual X-ray absorptiometry (DXA) and measurement of serum bone markers.
Volumetric bone mineral density (vBMD), cortical and trabecular microarchitecture.
CHH and controls did not differ for age, BMI, vitamin D and PTH levels. Despite long-term hormonal treatment (10.8 ± 6.8 years), DXA showed lower areal BMD in CHH/KS at lumbar spine, total hip, femoral neck and distal radius. Consistent with persistently higher serum bone markers, HR-pQCT revealed lower cortical and trabecular vBMD as well as cortical thickness at the tibia and the radius. CHH/KS men had altered trabecular microarchitecture with a predominant decrease of trabecular thickness. Moreover, CHH/KS men exhibited lower cortical bone area, whereas total and trabecular areas were higher only at the tibia. Earlier treatment onset (before the age of 19 years) conferred a significant advantage for trabecular bone volume/tissue volume and trabecular vBMD at the tibia.
Both vBMD and bone microarchitecture remain impaired in CHH/KS men despite long-term hormonal treatment. Treatment initiation during adolescence is associated with enhanced trabecular outcomes, highlighting the importance of early diagnosis.
Keywords
Congenital hypogonadotropic hypogonadism, HR-pQCT, Kallmann syndrome, androgen replacement therapy, bone microarchitecture, bone mineral density
Pubmed
Create date
27/03/2021 16:27
Last modification date
13/07/2021 6:36
Usage data